Your browser doesn't support javascript.
loading
Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry.
Laredo, Mikael; Duthoit, Guillaume; Sacher, Frédéric; Anselme, Frédéric; Audinet, Caroline; Bessière, Francis; Bordachar, Pierre; Bouzeman, Abdeslam; Boveda, Serge; Bun, Sok Sithikun; Chassignolle, Morgane; Clerici, Gaël; Da Costa, Antoine; de Guillebon, Maxime; Defaye, Pascal; Elbaz, Nathalie; Eschalier, Romain; Extramiana, Fabrice; Fauchier, Laurent; Hermida, Alexis; Gandjbakhch, Estelle; Garcia, Rodrigue; Gourraud, Jean-Baptiste; Guenancia, Charles; Guy-Moyat, Benoit; Irles, Didier; Iserin, Laurence; Jourda, François; Koutbi, Linda; Labombarda, Fabien; Ladouceur, Magalie; Lagrange, Philippe; Lellouche, Nicolas; Mansourati, Jacques; Marquié, Christelle; Martins, Raphael; Massoulié, Grégoire; Mathiron, Amel; Maury, Philippe; Messali, Anne; Milhem, Antoine; Mondoly, Pierre; Nguyen, Cédric; Ninni, Sandro; Pasquié, Jean Luc; Pierre, Bertrand; Pujadas, Penelope; Sellal, Jean-Marc; Thambo, Jean-Benoit; Walton, Camille.
Afiliação
  • Laredo M; Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.
  • Duthoit G; Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.
  • Sacher F; LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.
  • Anselme F; Rouen University Hospital, Rouen, France.
  • Audinet C; Bretagne Sud Hospital, Lorient, France.
  • Bessière F; Louis Pradel Hospital, Lyon, France.
  • Bordachar P; LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.
  • Bouzeman A; Parly II Private Hospital, Le Chesnay, France.
  • Boveda S; Pasteur Clinic, Toulouse, France.
  • Bun SS; Princess Grace Hospital, Monaco, France.
  • Chassignolle M; Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France.
  • Clerici G; Saint Pierre University Hospital, La Réunion, France.
  • Da Costa A; Saint Etienne University Hospital, Saint Etienne, France.
  • de Guillebon M; Pau Hospital, Pau, France.
  • Defaye P; Grenoble University Hospital, Grenoble, France.
  • Elbaz N; Henri-Mondor University Hospital, Créteil, France.
  • Eschalier R; Clermont Ferrand University Hospital, Clermont Ferrand, France.
  • Extramiana F; Bichat University Hospital, Paris, France.
  • Fauchier L; Tours University Hospital, Tours, France.
  • Hermida A; Amiens University Hospital, Amiens, France.
  • Gandjbakhch E; Unité de Rythmologie, Cardiology institute, Sorbonne University, AP-HP, La Pitié-Salpêtrière University Hospital, Paris, France.
  • Garcia R; Poitiers University Hospital, Poitiers, France.
  • Gourraud JB; Nantes University Hospital, Nantes, France.
  • Guenancia C; Dijon University Hospital, Dijon, France.
  • Guy-Moyat B; Limoges University Hospital, Limoges, France.
  • Irles D; Annecy Hospital, Annecy, France.
  • Iserin L; Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France.
  • Jourda F; Auxerre Hospital, Auxerre, France.
  • Koutbi L; La Timone Hospital, Marseille, France.
  • Labombarda F; Caen University Hospital, Caen, France.
  • Ladouceur M; Université de Paris, INSERM, Paris Cardiovascular Research Centre, Paris, France; Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France.
  • Lagrange P; Saint-Pierre Clinic, Perpignan, France.
  • Lellouche N; Henri-Mondor University Hospital, Créteil, France.
  • Mansourati J; Brest University Hospital, Brest, France.
  • Marquié C; Lille University Hospital, Lille, France.
  • Martins R; Rennes University Hospital, Rennes, France.
  • Massoulié G; Clermont Ferrand University Hospital, Clermont Ferrand, France.
  • Mathiron A; Amiens University Hospital, Amiens, France.
  • Maury P; Toulouse University Hospital, Toulouse, France.
  • Messali A; Bichat University Hospital, Paris, France.
  • Milhem A; La Rochelle Hospital, La Rochelle, France.
  • Mondoly P; Toulouse University Hospital, Toulouse, France.
  • Nguyen C; Chalon sur Saône Hospital, Chalon sur Saône, France.
  • Ninni S; Lille University Hospital, Lille, France.
  • Pasquié JL; Montpellier University Hospital, Montpellier, France.
  • Pierre B; Tours University Hospital, Tours, France.
  • Pujadas P; Les Franciscaines Clinic, Nîmes, France.
  • Sellal JM; Nancy University Hospital, Nancy, France.
  • Thambo JB; LIRYC Institute, Bordeaux University Hospital, Bordeaux, France.
  • Walton C; Louis Pradel Hospital, Lyon, France.
Heart Rhythm ; 20(2): 252-260, 2023 02.
Article em En | MEDLINE | ID: mdl-36309156
ABSTRACT

BACKGROUND:

In repaired tetralogy of Fallot (TOF), little is known about characteristics of patients with rapid ventricular tachycardia (VT). Also, whether patients with a first episode of nonrapid VT may subsequently develop rapid VT or ventricular fibrillation (VF) has not been addressed.

OBJECTIVES:

The objectives of this study were to compare patients with rapid VT/VF with those with nonrapid VT and to assess the evolution of VT cycle lengths (VTCLs) overtime.

METHODS:

Data were analyzed from a nationwide registry including all patients with TOF and implantable cardioverter-defibrillator (ICD) since 2000. Patients with ≥1 VT episode with VTCL ≤250 ms (240 beats/min) formed the rapid VT/VF group.

RESULTS:

Of 144 patients (mean age 42.0 ± 12.7 years; 104 [72%] men), 61 (42%) had at least 1 VT/VF episode, including 28 patients with rapid VT/VF (46%), during a median follow-up of 6.3 years (interquartile range 2.2-10.3 years). Compared with patients in the nonrapid VT group, those in the rapid VT/VF group were significantly younger at ICD implantation (35.2 ± 12.6 years vs 41.5 ± 11.2 years; P = .04), had more frequently a history of cardiac arrest (8 [29%] vs 2 [6%]; P = .02), less frequently a history of atrial arrhythmia (11 [42%] vs 22 [69%]; P = .004), and higher right ventricular ejection fraction (43.3% ± 10.3% vs 36.6% ± 11.2%; P = .04). The median VTCL of VT/VF episodes was 325 ms (interquartile range 235-429 ms). None of the patients with a first documented nonrapid VT episode had rapid VT/VF during follow-up.

CONCLUSION:

Patients with TOF and rapid VT/VF had distinct clinical characteristics. The relatively low variation of VTCL over time suggests a room for catheter ablation without a backup ICD in selected patients with well-tolerated VT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Taquicardia Ventricular / Desfibriladores Implantáveis Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Rhythm Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Taquicardia Ventricular / Desfibriladores Implantáveis Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Rhythm Ano de publicação: 2023 Tipo de documento: Article